KarenJVigilMDFACP, FIDSA(She/Her)
Infectious Disease • Houston, TXHIV/AIDS Medicine, STD Medicine
Associate Professor, Internal Medicine, McGovern Medical School at The University of Texas Health Science Center, Houston. Associate Medical Director - HIV Services - Thomas Street at Quentin Mease - Harris Health System. Quality Improvement Officer - Infectious Diseases - McGovern Medical School at UT Houston
Dr. Vigil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2015 Thomas St
Houston, TX 77009Phone+1 713-873-4000Fax+1 713-500-0730- Is this information wrong?
Education & Training
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2006 - 2008
Henry Ford HospitalResidency, Internal Medicine, 2003 - 2006
Cayetano Heredia UniversityClass of 2001
Certifications & Licensure
TX State Medical License 2009 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Respiratory Virus Outpatient Study (FLU 002 Plus) Start of enrollment: 2009 Aug 01
- Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP) Start of enrollment: 2011 May 01
- Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A R...O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I,...> ;JAMA.
- 4 citationsImmunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus.Kristen M Marks, Minhee Kang, Triin Umbleja, Anchalee Avihingsanon, Patcharaphan Sugandhavesa, Andrea L Cox, Karen Vigil, Hugo Perazzo, Jennifer C Price, Leolin Katsid...> ;Clinical Infectious Diseases. 2023 Aug 14
- Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD,...> ;The New England journal of medicine. 2021-08-04
- Join now to see all
Press Mentions
Pioneering Paper Shows Infection Control and Prevention in Clinics Is in Everyone’s HandsMay 3rd, 2018
Hospital Affiliations
Harris Health SystemHouston, Texas
Memorial Hermann - Texas Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
